BridgeBio Pharma, Inc. (NASDAQ: BBIO) Quarterly Earnings Preview

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is a biopharmaceutical company focused on developing treatments for genetic conditions. The company is set to release its quarterly earnings on February 24, 2026. Wall Street anticipates an earnings per share (EPS) of -$0.75 and revenue of around $149.1 million. BBIO will also host a conference call to discuss these results and provide business updates.BBIO's financial metrics reveal some challenges. The company has a negative price-to-earnings (P/E) ratio of -16.23, in ...